1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Zirah, S.
Kozin, S.A.
Mazur, A.K.
Blond, A.
Cheminant, M.
Segalas-Milazzo, I.
Debey, P.
Rebuffat, S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
281
2151
2161
10.1074/jbc.M504454200
16301322
Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging.
2006
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1984.093
16-mer from Alzheimer's disease amyloid Protein
1
syn
polymer
Alzheimer's disease amyloid A4 Protein, Amyloid beta A4 protein
no
yes
(ACE)DAEFRHDSGYEVHHQK(NH2)
XDAEFRHDSGYEVHHQKX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
Database references
1
0
2005-05-03
1
1
2008-04-30
1
2
2011-07-13
1
3
2013-10-09
the same peptide in TFE/WATER 80/20 solution
the same peptide complexed with a zinc (II) cation
RCSB
Y
PDBJ
2005-04-18
REL
REL
This sequence occurs naturally in humans.
sample
This structure was determined using standard 2D homonuclear techniques
target function
1000
20
DQF-COSY
2D TOCSY
2D NOESY
HSQC
HMBC
0.1
6.5
ambient
278
K
the structures are based on a total of 206 restraints, 201 are NOE-derived
distance constraints, 5 dihedral angle restraints
simulated annealing
1
closest to the average
2.8mM in 50mM sodium phosphate buffer
90% H2O/10% D2O
Bruker Biospin
processing
XWINNMR
3.1
Bruker Biospin
data analysis
AURELIA
1.6
Alexey K.Mazur
structure solution
ICMD
2.7
Alexey K.Mazur
refinement
ICMD
2.7
600
Bruker
DMX
ACE
0
n
1
ACE
0
A
ASP
1
n
2
ASP
1
A
ALA
2
n
3
ALA
2
A
GLU
3
n
4
GLU
3
A
PHE
4
n
5
PHE
4
A
ARG
5
n
6
ARG
5
A
HIS
6
n
7
HIS
6
A
ASP
7
n
8
ASP
7
A
SER
8
n
9
SER
8
A
GLY
9
n
10
GLY
9
A
TYR
10
n
11
TYR
10
A
GLU
11
n
12
GLU
11
A
VAL
12
n
13
VAL
12
A
HIS
13
n
14
HIS
13
A
HIS
14
n
15
HIS
14
A
GLN
15
n
16
GLN
15
A
LYS
16
n
17
LYS
16
A
NH2
17
n
18
NH2
17
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
12
A
A
OD2
HG
ASP
SER
1
8
1.57
2
A
ARG
5
0.132
SIDE CHAIN
1
A
PHE
4
-143.92
51.33
1
A
HIS
6
-144.16
14.89
2
A
HIS
6
-141.50
12.63
5
A
HIS
13
-137.09
-62.80
6
A
ARG
5
-138.30
-46.70
7
A
HIS
13
-131.62
-43.95
8
A
HIS
13
-143.67
-51.73
13
A
GLU
3
-87.14
41.85
13
A
PHE
4
-83.63
48.79
16
A
PHE
4
-143.68
25.23
17
A
ASP
7
-134.51
-34.74
19
A
PHE
4
-58.60
107.89
19
A
HIS
13
-137.44
-51.38
20
A
HIS
13
-137.63
-58.83
16-mer from Alzheimer's disease amyloid Protein
Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in water solution at pH 6.5
1
N
N
A
HIS
6
A
HIS
7
HELX_P
A
TYR
10
A
TYR
11
5
1
5
covale
1.325
A
ACE
0
A
C
ACE
1
1_555
A
ASP
1
A
N
ASP
2
1_555
covale
1.325
A
LYS
16
A
C
LYS
17
1_555
A
NH2
17
A
N
NH2
18
1_555
METAL BINDING PROTEIN
irregular structure, METAL BINDING PROTEIN
A4_HUMAN
UNP
1
672
P05067
DAEFRHDSGYEVHHQK
672
687
1ZE7
1
16
P05067
A
1
2
17
1
ACETYLATION
ACE
0
1ZE7
A
P05067
UNP
1
1
AMIDATION
NH2
17
1ZE7
A
P05067
UNP
18
BINDING SITE FOR RESIDUE NH2 A 17
Software
2
A
GLN
15
A
GLN
16
2
1_555
A
LYS
16
A
LYS
17
2
1_555